continue to monitor this issue closely,' Wyeth spokeswoman Gwen Fisher said. The FDA also said it was probing King Pharmaceuticals' (KG.N) Flector pain patch for hypersensitivity reactions and Medicis Pharmaceutical Corp's (MRX.N) Solodyn antibiotic for...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 2-Cancer, bowel drugs on U.S. FDA safety scrutiny list
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account